July 12, 2024

error page

Business is my step

SK Money Announces Settlement to Get Catalent’s Blow-Fill-Seal Sterile CDMO Company

3 min read
SK Money Announces Settlement to Get Catalent’s Blow-Fill-Seal Sterile CDMO Company
SK Money Announces Settlement to Get Catalent’s Blow-Fill-Seal Sterile CDMO Company

NEW YORK–(Enterprise WIRE)–Jan 6, 2021–

SK Funds Companions LP, a non-public financial commitment company focused on the specialty resources, chemical substances and prescription drugs sectors, today announced that cash it advises have signed a definitive agreement to obtain the Blow-Fill-Seal (“BFS”) Sterile Deal Advancement and Production Small business (the “Business”) from Catalent Pharma Methods, LLC. The acquisition of the Small business, which will function as a new independent company, is predicted to near in April of 2021.

The Company is a main BFS sterile contract growth and production group (CDMO) that operates out of a one web page in Woodstock, Illinois, focusing on sophisticated medical to business phase formulation and production. The Organization supports a international, blue-chip buyer foundation with a broad array of products that leverage its BFS sterile producing abilities and formulation competency in intricate chemistries which include modest molecule, biologics, macromolecules, and potent compounds.

Aaron Davenport, a Handling Director of SK Cash, stated, “Catalent’s BFS Business is a tested field leader in Blow-Fill-Seal sterile manufacturing with an uncompromising dedication to the optimum quality, basic safety, and dependability standards. We are energized about the option to partner with the administration and workers of the Business enterprise to generate a targeted and thriving independent company focused to delivering its consumers with the highest degrees of support.”

“Divesting our BFS manufacturing organization will make it possible for us to concentrate on our escalating main things to do of establishing oral, inhaled and biologic medicine with consumers, as properly as promptly extending our technological portfolio of new, rising modalities, together with cell and gene therapies,” commented Jonathan Arnold, President, Oral and Specialty Delivery at Catalent. He extra, “We would like to thank all people at the Woodstock facility for their dedication and determination to Catalent in their endeavours to help the start and provide of several important prescription drugs, and I am confident they will proceed to prosper underneath the new ownership, whose staff has intensive expertise investing into and rising pharmaceutical corporations.”

Dedicated credit card debt funding was supplied by Cerberus Business Finance, LLC. Mizuho Securities served as economic advisor and Kirkland & Ellis LLP acted as lawful counsel to SK Money. RBC Cash Markets served as fiscal advisor and Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as lawful counsel to Catalent.

About SK Cash

SK Capital is a personal expense business with a disciplined target on the specialty materials, chemicals and prescribed drugs sectors. The business seeks to construct strong and rising businesses that create significant extensive-expression economic value. SK Money utilizes its market, working and financial commitment experience to establish possibilities to remodel corporations into bigger performing organizations with improved strategic positioning, progress and profitability as effectively as decrease operating risk. SK Capital’s portfolio of businesses generates revenues of somewhere around $11 billion per year, employs additional than 15,000 persons globally and operates 135 crops in 28 nations. The organization at the moment has roughly $4.86 billion of assets underneath administration. For more data, please go to www.skcapitalpartners.com.

Look at resource model on businesswire.com:https://www.businesswire.com/news/home/20210106005185/en/

Get hold of: Jeremy Milner

BackBay Communications

401-862-9422

[email protected]

Search term: UNITED STATES NORTH The usa NEW YORK

Sector Keyword: Professional Expert services Overall health FINANCE BANKING PHARMACEUTICAL BIOTECHNOLOGY

Supply: SK Capital Associates LP

Copyright Business Wire 2021.

PUB: 01/06/2021 07:00 AM/DISC: 01/06/2021 07:01 AM

http://www.businesswire.com/information/property/20210106005185/en

error-page.com © All rights reserved. | Newsphere by AF themes.